Altre lingue MusclePharm Corporation

Azioni

MSLP

US6273352012

Tempo differito OTC Markets Altri mercati azionari 21:28:56 03/04/2024			Variaz. 5gg	Var. 1 gen.
0,000001 ^USD	-99,92%		-.--%	-.--%

2023	Approvata la seconda richiesta di estensione del periodo di esclusività per MusclePharm Corporation	CI
2023	FitLife Brands, Inc. (NasdaqCM:FTLF) ha completato l'acquisizione della quasi totalità delle attività di MusclePharm Corporation (OTCPK:MSLP.Q).	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	18/10/23
FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).	10/10/23
Motion for Asset Sale Approved for MusclePharm Corporation	03/10/23
FitLife Brands, Inc. entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.	27/09/23
Stalking Horse Agreement Filed by MusclePharm Corporation	08/09/23
Musclepharm Corporation Announces Resignation of Paul Karr as Director	31/08/23
Second Amended Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	28/08/23
First Amended Disclosure Statement Approved for MusclePharm Corporation	28/08/23
Bidding Procedure Approved for MusclePharm Corporation	17/08/23
Musclepharm Corporation Terminates Gary Shirshac as Chief Financial Officer	19/07/23
SEC Charges Former MusclePharm Executives with Accounting and Disclosure Fraud	28/06/23
First Amended Reorganization Plan and DIsclosure Statement Filed by MusclePharm Corporation	19/06/23
Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	26/05/23
Motion for Asset Sale Filed by MusclePharm Corporation	12/05/23
First Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	10/05/23
MusclePharm Corporation has withdrawn its IPO in the amount of $10 million.	16/04/23
First Motion for Exclusivity Period Extension Filed by MusclePharm Corporation	10/04/23
DIP Financing Approved for MusclePharm Corporation	08/03/23
Amended DIP Financing Approved for MusclePharm Corporation	23/01/23
Interim DIP Financing Approved for MusclePharm Corporation	09/01/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue MusclePharm Corporation

Azioni

MSLP

US6273352012

Altre lingue

Filtri